MyD88 in myofibroblasts regulates aerobic glycolysis‐driven hepatocarcinogenesis via ERK ‐dependent PKM2 nuclear relocalization and activation
- 19 December 2021
- journal article
- research article
- Published by Wiley in The Journal of Pathology
- Vol. 256 (4) , 414-426
Abstract
Hepatic stellate cells (HSCs) and cancer‐associated fibroblasts (CAFs) play critical roles in liver fibrosis and hepatocellular carcinoma (HCC). MyD88 controls the expression of several key modifier genes in liver tumorigenesis; however, whether and how MyD88 in myofibroblasts contributes to the development of fibrosis‐associated liver cancer remains elusive. Here, we used an established hepatocarcinogenesis mouse model involving apparent liver fibrogenesis in which MyD88 was selectively depleted in myofibroblasts. Myofibroblast MyD88‐deficient (Fib‐MyD88 KO) mice developed significantly fewer and smaller liver tumor nodules. MyD88 deficiency in myofibroblasts attenuated liver fibrosis and aerobic glycolysis in hepatocellular carcinoma tissues. Mechanistically, MyD88 signaling in myofibroblasts increased the secretion of CCL20, which promoted aerobic glycolysis in cancer cells. This process was dependent on the CCR6 receptor and ERK/PKM2 signaling. Furthermore, liver tumor growth was greatly relieved when the mice were treated with a CCR6 inhibitor. Our data revealed a critical role for MyD88 in myofibroblasts in the promotion of hepatocellular carcinoma by affecting aerobic glycolysis in cancer cells and might provide a potential molecular therapeutic target for HCC. © 2021 The Pathological Society of Great Britain and Ireland.Keywords
Funding Information
- Ministry of Science and Technology of the People's Republic of China (2015CB553705)
- National Natural Science Foundation of China (81772497, 81972689)
This publication has 50 references indexed in Scilit:
- Myeloid Differentiation Factor 88 Promotes Growth and Metastasis of Human Hepatocellular CarcinomaClinical Cancer Research, 2013
- Fibrosis-dependent mechanisms of hepatocarcinogenesisHepatology, 2012
- In Vivo Fate Mapping Identifies Mesenchymal Progenitor CellsStem Cells, 2012
- Hepatic stellate cells stimulate HCC cell migration via laminin-5 productionClinical Science, 2011
- Pathogenesis of Liver FibrosisAnnual Review of Pathology: Mechanisms of Disease, 2011
- Hepatitis B virus X protein stimulates IL-6 expression in hepatocytes via a MyD88-dependent pathwayJournal of Hepatology, 2011
- Matrix stiffness modulates proliferation, chemotherapeutic response, and dormancy in hepatocellular carcinoma cellsHepatology, 2010
- Distinct Patterns of Cytokine and Angiogenic Factor Modulation and Markers of Benefit for Vandetanib and/or Chemotherapy in Patients With Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2010
- Transforming growth factor-β and substrate stiffness regulate portal fibroblast activation in cultureHepatology, 2007
- Gender Disparity in Liver Cancer Due to Sex Differences in MyD88-Dependent IL-6 ProductionScience, 2007